Trial Profile
DRUG USE INVESTIGATION OF EFFEXOR(REGISTERED) SR CAPSULES
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2023
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Depression; Depressive disorders
- Focus Adverse reactions
- Sponsors Pfizer
- 15 Jun 2020 Status changed from active, no longer recruiting to completed.
- 01 Apr 2020 Planned End Date changed from 11 Mar 2020 to 11 May 2020.
- 01 Apr 2020 Planned primary completion date changed from 11 Mar 2020 to 11 May 2020.